Elixir Pharmaceuticals
Elixer Pharmaceuticals, no longer operating, was focused on the discovery, development, and commercialization of pharmaceuticals for treating metabolic diseases, such as diabetes and obesity.
2
Funding Rounds
$58.0m
Money raised
Overview
Elixer Pharmaceuticals, no longer operating, was focused on the discovery, development, and commercialization of pharmaceuticals for treating metabolic diseases, such as diabetes and obesity.
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Elixir Pharmaceuticals has raised a total of $58m in funding over 2 rounds.
Key Insights:
- Elixir Pharmaceuticals Series D round: $12m
- Elixir Pharmaceuticals Series C round: $46m
Elixir Pharmaceuticals Series D round
$12m
Elixir Pharmaceuticals Series C round
$46m
Industries
Elixir Pharmaceuticals is active in the following industries: